This is a StreetInsider.com Premium Only Page

(SEEL) –

Mar 28, 2024 08:00 AM Form 8-K SEELOS THERAPEUTICS, For: Mar 27

Mar 19, 2024 04:06 PM Form 8-K SEELOS THERAPEUTICS, For: Mar 19

Mar 19, 2024 08:16 AM Seelos Therapeutics (SEEL) Provides Update on Top-Line Results from its ALS Study

Mar 19, 2024 08:15 AM Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose)

Mar 18, 2024 06:05 AM Form EFFECT SEELOS THERAPEUTICS,

Mar 15, 2024 04:25 PM Seelos Therapeutics (SEEL) Announces 3.4M Share Offering by Selling Stockholders

Mar 15, 2024 04:19 PM Form 424B3 SEELOS THERAPEUTICS,

Mar 7, 2024 06:01 AM Form S-8 SEELOS THERAPEUTICS,

Mar 6, 2024 05:32 PM Form S-1/A SEELOS THERAPEUTICS,

Mar 6, 2024 04:51 PM Form 10-K SEELOS THERAPEUTICS, For: Dec 31

Mar 1, 2024 05:39 PM Form 4 SEELOS THERAPEUTICS, For: Feb 29 Filed by: Golembiewski Michael Joseph

Feb 14, 2024 05:13 PM Form D SEELOS THERAPEUTICS,

Feb 6, 2024 05:27 PM Form SC 13G SEELOS THERAPEUTICS, Filed by: Lind Global Fund II LP

Feb 2, 2024 06:17 AM Seelos Therapeutics (SEEL) Announces 3.4M Share Offering by Selling Stockholders

Feb 2, 2024 06:05 AM Form S-1 SEELOS THERAPEUTICS,

Jan 30, 2024 04:02 PM Form 8-K SEELOS THERAPEUTICS, For: Jan 26

Jan 30, 2024 06:06 AM Form 424B5 SEELOS THERAPEUTICS,

Jan 26, 2024 08:30 AM Seelos Therapeutics (SEEL) Prices 3.4M Share Offering at $1.175/sh

Jan 26, 2024 08:30 AM Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Jan 22, 2024 08:06 AM Form 8-K SEELOS THERAPEUTICS, For: Jan 22

Jan 22, 2024 08:01 AM Seelos Therapeutics (SEEL) Receives Minutes from its End of Phase II Meeting with the FDA

Jan 22, 2024 08:00 AM Seelos Therapeutics Announces Receipt of Minutes from its End of Phase II Meeting with the United States Food and Drug Administration (FDA) Highlighting Modifications to the Primary and Secondary Endp

Jan 17, 2024 09:48 PM Form 4 SEELOS THERAPEUTICS, For: Jan 12 Filed by: Mehra Raj

Jan 17, 2024 09:47 PM Form 4 SEELOS THERAPEUTICS, For: Jan 12 Filed by: Golembiewski Michael Joseph

Jan 10, 2024 04:17 PM Form 8-K SEELOS THERAPEUTICS, For: Jan 10

Jan 8, 2024 09:46 PM Form 4 SEELOS THERAPEUTICS, For: Jan 04 Filed by: DALESANDRO MARGARET

Jan 8, 2024 09:46 PM Form 4 SEELOS THERAPEUTICS, For: Jan 04 Filed by: Pascoe Richard W

Jan 8, 2024 09:46 PM Form 4 SEELOS THERAPEUTICS, For: Jan 04 Filed by: Lian Brian

Jan 8, 2024 09:45 PM Form 4 SEELOS THERAPEUTICS, For: Jan 04 Filed by: O'Connor Daniel J.

Jan 2, 2024 08:11 AM Form DEFA14A SEELOS THERAPEUTICS,

Jan 2, 2024 08:00 AM Leading Independent Proxy Advisory Firm ISS Recommends Seelos Stockholders Vote "FOR" All Proxy Proposals at the Special Meeting to be held on January 10, 2024

Dec 28, 2023 06:03 AM Form EFFECT SEELOS THERAPEUTICS,

Dec 22, 2023 04:02 PM Form DEFA14A SEELOS THERAPEUTICS,

Dec 22, 2023 08:10 AM Form DEFA14A SEELOS THERAPEUTICS,

Dec 22, 2023 08:02 AM Seelos Therapeutics (SEEL) Issues Letter to its Stockholders

Dec 22, 2023 08:00 AM Seelos Therapeutics, Inc. Releases Letter to its Stockholders

Dec 20, 2023 04:59 PM Form DEFA14A SEELOS THERAPEUTICS,

Dec 20, 2023 04:55 PM Form DEFA14A SEELOS THERAPEUTICS,

Dec 18, 2023 04:56 PM Seelos Therapeutics (SEEL) Files $250M Mixed Shelf

Dec 18, 2023 04:54 PM Form S-3 SEELOS THERAPEUTICS,

Dec 15, 2023 04:07 PM Form DEF 14A SEELOS THERAPEUTICS, For: Jan 10

Dec 4, 2023 04:06 PM Form PRE 14A SEELOS THERAPEUTICS, For: Dec 04

Dec 1, 2023 04:17 PM Form 4 SEELOS THERAPEUTICS, For: Nov 30 Filed by: Golembiewski Michael Joseph

Dec 1, 2023 04:16 PM Form 4 SEELOS THERAPEUTICS, For: Dec 01 Filed by: Mehra Raj

Dec 1, 2023 04:09 PM Form 8-K SEELOS THERAPEUTICS, For: Dec 01

Dec 1, 2023 04:00 PM Seelos Therapeutics Announces Closing of Public Offering

Nov 30, 2023 05:00 PM Form 8-K SEELOS THERAPEUTICS, For: Nov 27

Nov 30, 2023 04:59 PM Form 424B5 SEELOS THERAPEUTICS,

Nov 29, 2023 06:12 AM Seelos Therapeutics (SEEL) prices 1.78M share offering w/warrants

Nov 28, 2023 09:26 PM Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering